PMID: 6409465Jul 1, 1983Paper

Glucose and ketone body kinetics in diabetic ketoacidosis

Clinics in Endocrinology and Metabolism
J M Miles, J E Gerich

Abstract

The hyperglycaemia and hyperketonaemia of diabetic ketoacidosis are initiated primarily by overproduction of these substrates; subsequent maintenance of hyperglycaemia occurs, in large part, due to impaired utilization of glucose, whereas overproduction of ketone bodies continues to be the major mechanism for maintenance of hyperketonaemia. Insulin deficiency results in increased rates of lipolysis and provides increased substrate (free fatty acids) for ketogenesis. Hyperglucagonaemia can augment ketogenesis further in the setting of insulin deficiency. It is likely that other counter-insulin hormones (growth hormone, catecholamines) also contribute to the pathogenesis of DKA, though their role is less well defined. Insulin corrects DKA largely via suppression of lipolysis (and thus ketone body production); insulin suppresses glucose production at lower levels than it does ketone body production.

References

Jul 1, 1977·Clinics in Endocrinology and Metabolism·K G Alberti, T D Hockaday
Jul 1, 1979·Diabetologia·J A LuttermanA van 't Laar
Sep 1, 1978·Diabetes Care·R S Clements, B Vourganti
May 1, 1979·Diabetes Care·D S Schade, R P Eaton
Sep 1, 1978·The Journal of Clinical Endocrinology and Metabolism·D S SchadeJ Standefer
Apr 1, 1977·Metabolism: Clinical and Experimental·O E OwenG A Richard
Jun 2, 1977·The New England Journal of Medicine·A J BarnesD J Chisholm
Aug 4, 1977·The New England Journal of Medicine·J N FisherA E Kitabchi
Oct 1, 1977·Archives of Internal Medicine·K G Alberti
May 1, 1978·Annals of Internal Medicine·R A Kreisberg
Oct 15, 1979·The Biochemical Journal·J A CarnieM Mavris-Vavayannis
May 1, 1978·The Journal of Clinical Investigation·H NakabayashiR H Unger
May 8, 1975·The New England Journal of Medicine·J E GerichP H Forsham
May 20, 1976·The New England Journal of Medicine
Jun 1, 1977·The Journal of Clinical Endocrinology and Metabolism·D S SchadeJ Standefer
Sep 1, 1975·Metabolism: Clinical and Experimental·E O Balasse, M A Neef
Nov 1, 1975·The Journal of Clinical Investigation·D S Schade, R P Eaton
Feb 12, 1976·The New England Journal of Medicine·L L Madison
Jun 9, 1973·British Medical Journal·J F MunroL J Duncan
Jul 14, 1973·British Medical Journal·J T Ireland, W S Thomson
Jun 13, 1974·The New England Journal of Medicine·P Felig
Sep 1, 1974·Diabetes·R ParrillaC J Toews
Jan 1, 1974·The Journal of Clinical Investigation·J E LiljenquistG W Liddle
Jun 29, 1974·British Medical Journal·M M PageT E West
Apr 1, 1971·The Journal of Clinical Investigation·E O Balasse, R J Havel
Aug 1, 1970·Metabolism: Clinical and Experimental·E J DrenickH Elrick
Sep 1, 1970·The Journal of Clinical Investigation·F A BieberdorfR O Scow

❮ Previous
Next ❯

Citations

Apr 1, 1990·Journal of Anesthesia·M OgataA Shigematsu
Jan 10, 2001·Endocrinology and Metabolism Clinics of North America·M F DelaneyW M Kettyle
Apr 15, 2000·Journal of Diabetes and Its Complications·Y S YunK B Huh
Mar 31, 2009·Current Medical Research and Opinion·Christian WeberShashank R Joshi
Feb 1, 1986·Metabolism: Clinical and Experimental·I J ChopraG N Chua Teco
Jan 11, 2008·Diabetes Care·Mae Sheikh-AliJohn M Miles
Jul 1, 2009·Diabetes Care·Abbas E KitabchiJoseph N Fisher
May 27, 2008·Pediatric Clinics of North America·James P OrlowskiMariano R Fiallos
Nov 23, 2005·Pediatric Clinics of North America·Nicole Glaser
Sep 5, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·E IoriA Avogaro
Jan 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·A J KrentzM Nattrass
Dec 4, 2010·Indian Journal of Pediatrics·Sindhu SivanandanRakesh Lodha
Oct 30, 2018·International Journal of Endocrinology·Xiaofang YuLong Zhang
May 31, 2019·BMJ : British Medical Journal·Esra Karslioglu FrenchMary T Korytkowski
Feb 2, 2021·American Journal of Physiology. Endocrinology and Metabolism·André C Carpentier
Jun 10, 2021·Medicine, Science, and the Law·Daniel LewisRoger W Byard
Oct 18, 2012·Analytical Chemistry·Andrew A VaughanRoyston Goodacre

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pediatric Emergency Care
Ronn E Tanel
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Kevin KaisermanJessie L Fahrbach
© 2021 Meta ULC. All rights reserved